Web Exclusives

A recent study found that chronic pneumonitis is a rare complication of immune checkpoint inhibitor therapy in patients with NSCLC. Read More ›

A retrospective analysis demonstrated a 10-point difference in receipt of NGS testing between white and black patients with NSCLC. Read More ›

Recently released study results report similar chemo-immunotherapy outcomes in KRAS-mutant NSCLC subtypes and poor results in patients with concurrent STK11 and/or KEAP1 mutations. Read More ›

A recently released retrospective study demonstrates that NSAID use in patients with NSCLC enhances immune checkpoint efficacy. Read More ›

Subgroup analysis of CodeBreaK 100 trial results found that sotorasib achieved a response in pretreated patients with KRASG12C-mutated NSCLC subtypes. Read More ›

Results from an incidental lung nodule program implemented in a community healthcare system demonstrates this program detects lung cancer in patients who are otherwise ineligible for LDCT screening. Read More ›

While the precise mechanism is unclear, clinicians’ expression of empathy vastly improves patient retention of information. Read More ›

Diet and exercise should be consistently addressed as part of oncology visits for improved patient outcomes. Read More ›

Treatment with CDK4/6 inhibitors in the presence of visceral crisis at diagnosis was linked with an improvement in overall survival. Read More ›

Study results show that a caregiver’s involvement can significantly moderate patient activation and adherence to treatment. Read More ›

Page 10 of 47

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: